Log in
Forgot password ?
Become a member for free
Sign up
Sign up
Dynamic quotes 

MarketScreener Homepage  >  Equities  >  Xetra  >  Bayer AG    BAYN   DE000BAY0017


News SummaryMost relevantAll newsOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

Bayer : Earmarks over $5 Billion for New Weed-Management Strategies in the Next Decade

share with twitter share with LinkedIn share with facebook
share via e-mail
06/15/2019 | 06:36am EDT

Farmers who are struggling with weeds during this rain-soaked spring will receive some long-term help from Bayer AG.

The German firm is earmarking approximately 5 billion euros ($5.64 billion) for new weed-fighting tools in the next decade. Its part of a transparency and sustainability initiative that Bayer AG announced this week to reduce its environmental impact globally by 30% by 2030.

Bayer aims to do this through new technologies, scaling down crop-production volumes and more precise application.

Bayer officials say it will help restore and retain biodiversity, combat climate change, and make the most efficient use of natural resources. Were making good progress on integrating the acquired agriculture business (Monsanto) and are now starting to implement a series of measures to drive transparency and sustainability across our business, said Werner Baumann, Bayer AGs chairman of the board of management, in a Bayer news release.

Given this soggy spring, Bayer is sensitive to the fact that U.S. farmers are still concentrating on planting and managing crops going in the ground, says Darren Wallis, a Bayer spokesman. Long term, though, the $5 billion-plus investment will enable Bayer to find new solutions for farmers battling weed resistance via integrated weed management, he says.

Some steps include:

Discovering and developing new herbicide sites of action.

Bob Reiter, global head of research and development for Bayer Crop Science, has pointed out that Bayer is working on a new herbicide site of action for corn and soybeans that may debut in in the late 2020s.

New digital tools and precision application.

Potential new partnerships with other firms.

Wallis adds that bringing Monsanto into Bayers fold last year will also aid the development of weed-fighting tools to farmers. "From the very onset, we, said we could do more together faster than we could do when apart, he says.

Environmental Impact Quotient

Bayer will measure its environmental impact progress by comparing a measure called an environmental impact quotient (EIQ) against the current market standards. The EIQ was established in the 1990s by Cornell University researchers. It relates product volume to toxicity. Bayer officials say it is a better measuring system than by produce volume only.

Officials for Bayer say it will improve the EIQ of its crop products by investing in:

Seeds and trait innovation

Digital farming

Biological solutions

Low-residue and reduced-rate application products

Holding Firm on Glyphosate

Wallis says the initiative is not being driven by recent cancer lawsuits against Bayer relating to its glyphosate-based Roundup products. We absolutely stand behind glyphosate and its safety profile and will continue to defend it in court, says Wallis. Regulatory bodies around the world have reviewed glyphosate and continue to confirm its safety and efficacy when used according to the label. Roundup and Xtend (glyphosate- and dicamba-tolerant weed-management systems) are important platforms and tools for growers. This (the initiative) is about (developing) even more tools and innovation that we will build on top of that.

Bayer officials say the initiative also builds upon transparency efforts the firm started in 2017. That year, Bayer began releasing all of its safety-related crop science studies online. Since then, officials for Bayer say it has released hundreds of studies for nearly 30 compounds, including all 107 company-owned glyphosate studies. This initiative also includes a program inviting scientists, journalists, and NGO representatives to participate through its scientific preparation for the upcoming EU glyphosate reregistration process, which will start later this year.

Bayer officials say the company will also continue to apply consistent safety standards to its products even those that exceed local regulations. Since 2012, Bayer has stopped selling all products that were considered acute toxicity class 1 by the World Health Organization, regardless of whether they were allowed in a particular market.

Bayer officials also announced the firm will only sell crop-protection products in markets that meet both the safety standards of that local market and the safety standards of a majority of countries with programs to regulate crop-protection products.

(c) 2019 The Jordan Times. All rights reserved. Provided by SyndiGate Media Inc. (Syndigate.info)., source Middle East & North African Newspapers

share with twitter share with LinkedIn share with facebook
share via e-mail
Latest news on BAYER AG
07/19BAYER : Syngenta profits hit by U.S./China trade wars, bad weather
07/19BAYER : welcomes judge's call for reduced damages in $2 billion glyphosate case
07/19BAYER : Correction to Bayer Verdict Article
07/19Does renewables pioneer Germany risk running out of power?
07/19BAYER : Judge Cuts Third Bayer Roundup Verdict in Tentative Ruling
07/17BAYER : Leads Investment in U.S. Oncology Startup
07/17Activist hedge fund Elliott takes stake in UK's Saga
07/16GRAIN HIGHLIGHTS : Top Stories of the Day
07/16LIVESTOCK HIGHLIGHTS : Top Stories of the Day
07/16BAYER : moving 500 jobs from North Carolina to St. Louis
More news
Financials (EUR)
Sales 2019 46 326 M
EBIT 2019 8 877 M
Net income 2019 3 589 M
Debt 2019 37 542 M
Yield 2019 4,80%
P/E ratio 2019 17,0x
P/E ratio 2020 12,4x
EV / Sales2019 2,01x
EV / Sales2020 1,90x
Capitalization 55 496 M
Duration : Period :
Bayer AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BAYER AG
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus OUTPERFORM
Number of Analysts 29
Average target price 77,90  €
Last Close Price 59,51  €
Spread / Highest target 107%
Spread / Average Target 30,9%
Spread / Lowest Target -34,9%
EPS Revisions
Werner Baumann Chairman-Management Board
Werner Wenning Chairman-Supervisory Board
Wolfgang U. Nickl Chief Financial Officer
Katharina Jansen Head-Science & Research
Hartmut Klusik Head-Human Resources, Technology & Sustainability
Sector and Competitors
1st jan.Capitalization (M$)
BAYER AG-1.67%62 271
JOHNSON & JOHNSON2.34%345 980
PFIZER-1.35%237 451
ROCHE HOLDING LTD.11.42%230 263
ROCHE HOLDING13.37%230 263
NOVARTIS24.46%216 273